Acute Porphyria Drugs

Monograph

R01AX03 - Ipratropium Bromide
Not porphyrinogenic
NP

Rationale
Hydrophilic substance, insignificant systemic exposure.
Chemical description
Ipratropium bromide, anticholinergic used in treatment (nasal spray 21 - 42 µg/dose) of rhinitis. Plasma levels below detection limit, only 3 - 6 % of the dose recovered in urine.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes R01A / R01AX or go back.
References
Tradenames

Atrovent Ipratropium bromide · Rinaspray Atrovent · Iprazap · Lomuspray Atrovent · Ipratropium · Lomuspray · Pms-Ipratropium Lomuspray Atrovent · Rinivent Atrovent
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙